Key result
Intravenous eptifibatide restores coronary blood flow in STEMI complicated by no-reflow.
Why the study?
Coronary no-reflow phenomenon is a common complication of primary PCI with many unresolved clinical issues despite extensive study.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
May aid no-reflow rescue in STEMI PCI; leaves open need for randomized confirmation.
Coronary no-reflow phenomenon (CNR) is a complication of primary percutaneous coronary intervention (PCI). According to different reports, CNR occurs in 10 to 60 % of cases. Despite the long history of studying this phenomenon many issues remain unsolved. This article presents a clinical case of electrocardiographically confirmed ST-segment elevation myocardial infarction. In this case, the CNR phenomenon occurred during PCI and was associated with heart rhythm disorders, left ventricular (LV) cavity dilatation with a decrease in LV contractility, and formation of intracavitary thrombus. The patient asked for medical care late, which could influence the development of CNR. This case demonstrates the clinical significance, diagnostic characteristics, and successful drug correction of the no-reflow phenomenon.
No takes yet. Share an insight, caveat, or question.
Константинова et al. (2020) conducted a case report in ST-segment elevation myocardial infarction (STEMI) with no-reflow phenomenon (n=1). Eptifibatide was evaluated on Restoration of coronary blood flow. Intravenous administration of eptifibatide successfully restored coronary blood flow in a 65-year-old man who developed the no-reflow phenomenon during primary percutaneous coronary intervention for STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: